Comparative efficacy of the new cardiotonic agent DPI 201-106 versus dobutamine in dilated cardiomyopathy: analysis by serial pressure/volume relations and "on-line" MVO2 assessment.
Thormann, J
Comparative efficacy of the new cardiotonic agent DPI 201-106 versus dobutamine in dilated cardiomyopathy: analysis by serial pressure/volume relations and "on-line" MVO2 assessment. [electronic resource] - Journal of cardiovascular pharmacology - 749-57 p. digital
Publication Type: Comparative Study; Journal Article
0160-2446
Adult
Cardiomyopathy, Dilated--drug therapy
Cardiotonic Agents--therapeutic use
Dobutamine--therapeutic use
Female
Heart Ventricles--diagnostic imaging
Humans
Male
Microcomputers
Middle Aged
Myocardial Contraction--drug effects
Myocardium--metabolism
Online Systems
Oxygen Consumption--drug effects
Piperazines--therapeutic use
Radiography
Comparative efficacy of the new cardiotonic agent DPI 201-106 versus dobutamine in dilated cardiomyopathy: analysis by serial pressure/volume relations and "on-line" MVO2 assessment. [electronic resource] - Journal of cardiovascular pharmacology - 749-57 p. digital
Publication Type: Comparative Study; Journal Article
0160-2446
Adult
Cardiomyopathy, Dilated--drug therapy
Cardiotonic Agents--therapeutic use
Dobutamine--therapeutic use
Female
Heart Ventricles--diagnostic imaging
Humans
Male
Microcomputers
Middle Aged
Myocardial Contraction--drug effects
Myocardium--metabolism
Online Systems
Oxygen Consumption--drug effects
Piperazines--therapeutic use
Radiography